HAP Trading’s Core Laboratories CLB Stock Holding History

HAP Trading’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,801	Closed	-$1.21M	–	1005
2016 Q3	$1.21M	Buy	+10,801	New	+$1.24M	0.04%	233

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

HAP Trading's CLB Position: Q4 2016 in Review

HAP Trading sold out of Core Laboratories (CLB) in Q4 2016, closing a stake of 10,801 shares — an estimated $1.21M sold.

HAP Trading first reported a position in CLB in Q3 2016 and held it in 1 quarter. The position peaked at $1.21M in Q3 2016. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

HAP Trading reported no remaining Core Laboratories position as of Q4 2016 after selling out during the quarter.
HAP Trading sold 10,801 Core Laboratories shares in Q4 2016, an estimated $1.21M.
HAP Trading first reported a position in Core Laboratories in Q3 2016 and held it in 1 quarter.
HAP Trading's Core Laboratories position peaked at $1.21M in Q3 2016.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on HAP Trading's 13F filing for Q4 2016, filed 10 Feb 2017.